Back to top
more

Organon & Co. (OGN)

(Real Time Quote from BATS)

$19.65 USD

19.65
465,109

+0.60 (3.15%)

Updated Aug 8, 2024 11:46 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 250)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Organon (OGN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

Although the revenue and EPS for Organon (OGN) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Organon (OGN) Surpasses Q2 Earnings Estimates

by Zacks Equity Research

Organon (OGN) delivered earnings and revenue surprises of 5.66% and 1.13%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Product Demand Likely to Aid Organon's (OGN) Q2 Earnings

by Zacks Equity Research

Continued solid uptake of Organon's (OGN) products is expected to have driven second-quarter revenues.

Do Options Traders Know Something About Organon (OGN) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to Organon (OGN) stock based on the movements in the options market lately.

Seeking Clues to Organon (OGN) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

by Zacks Equity Research

Besides Wall Street's top -and-bottom-line estimates for Organon (OGN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.

Organon (OGN) Stock Falls Amid Market Uptick: What Investors Need to Know

by Zacks Equity Research

In the latest trading session, Organon (OGN) closed at $21.86, marking a -1.84% move from the previous day.

Is WisdomTree U.S. SmallCap Dividend ETF (DES) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for DES

Earnings Preview: Organon (OGN) Q2 Earnings Expected to Decline

by Zacks Equity Research

Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Zacks Equity Research

Sector ETF report for PSCH

Urmimala Biswas headshot

3 Medical Services Industry Stocks to Buy as Healthcare Wage Increases

by Urmimala Biswas

The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ICLR, OGN and DOCS are set to gain the most. Healthcare staffing shortages are leading to an increase in labor wages.

Shaun Pruitt headshot

Stocks to Watch for a Potential Kamala Harris Presidency

by Shaun Pruitt

Let's discuss a few stocks and sectors that should be kept in mind for a potential Kamala Harris presidency as opposed to the Biden or Trump trade.

Organon (OGN) Upgraded to Strong Buy: What Does It Mean for the Stock?

by Zacks Equity Research

Organon (OGN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store.

Organon (OGN) Increases Yet Falls Behind Market: What Investors Need to Know

by Zacks Equity Research

In the closing of the recent trading day, Organon (OGN) stood at $20.81, denoting a +0.39% change from the preceding trading day.

Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note

by Zacks Equity Research

In the most recent trading session, Organon (OGN) closed at $19.93, indicating a -1.04% shift from the previous trading day.

Do Options Traders Know Something About Organon (OGN) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to Organon (OGN) stock based on the movements in the options market lately.

Organon (OGN) Stock Sinks As Market Gains: Here's Why

by Zacks Equity Research

In the most recent trading session, Organon (OGN) closed at $20.63, indicating a -0.77% shift from the previous trading day.

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Encompass Health (EHC) Gains 30% in a Year: More Room to Run?

by Zacks Equity Research

Encompass Health (EHC) is well-poised for growth on the back of sustained top-line growth, an aging U.S. population, frequent expansion initiatives and strong cash reserves.

Is Ocugen (OCGN) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Ocugen (OCGN) and Organon (OGN) have performed compared to their sector so far this year.

Humana's (HUM) CenterWell Expands in Louisiana With New Centers

by Zacks Equity Research

Humana's (HUM) CenterWell unit is likely to benefit from the opening of four new centers in the Baton Rouge and New Orleans areas in Louisiana, thus enhancing healthcare access for local seniors.

Organon (OGN) Advances While Market Declines: Some Information for Investors

by Zacks Equity Research

Organon (OGN) closed the most recent trading day at $20.45, moving +0.49% from the previous trading session.

Should WisdomTree U.S. SmallCap Dividend ETF (DES) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for DES

Compelling Reasons to Hold on to HCA Healthcare (HCA) Stock

by Zacks Equity Research

HCA Healthcare (HCA) remains well-poised for growth on the back of improved revenues, a well-diversified healthcare portfolio and solid cash-generating abilities.

Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.